Avoid common mistakes on your manuscript.
Dear Reader
As we reach the final issue of Pediatric Drugs for 2013, we hope that you have found the articles published throughout the year to be interesting and informative. The editors and publishing staff have appreciated the high quality of content contributed to the journal this year. The publishing schedule for 2014 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.
The quality of articles published in Pediatric Drugs was acknowledged in the new Impact Factor for 2012, which increased by 5.5 % to 1.884. The journal is now placed 43rd out of 121 in the Pediatrics category. The Adis portfolio as a whole saw impressive Impact Factor gains, with flagship journals continuing to increase their citations – Drugs raised its Impact Factor to 4.633, with Clinical Pharmacokinetics and Sports Medicine also seeing significant rises to 6.109 and 5.237, respectively. Pharmacoeconomics remains the number one journal in its field, and The Patient: Patient-Centered Outcomes Research saw an increase of more than 170% in its Impact Factor to 1.565, only one year after first appearing in the Journal Citation Reports®.
2013 saw the successful integration of the Adis portfolio of journals into the Springer production systems and custom-built platforms (SpringerLink, Springer for R&D, and Springer for Hospitals & Health). We are confident that our authors and subscribers benefit from improved discoverability, mobile optimisation and robust delivery of content on these platforms; and Springer production capacity has allowed us to increase the number of articles published whilst considerably reducing submission-to-publication times across the portfolio.
Looking ahead to 2014, the Adis portfolio will continue to grow the amount of content published while maintaining high standards. The number of Adis titles will also increase as existing quality Springer journals are brought under the Adis brand - Advances in Therapy, Targeted Oncology, and the European Journal of Drug Metabolism and Pharmacokinetics. Adis are also committed to fostering Open Access publication: all Adis titles offer the Springer Open Choice option and we are adding a further 10 fully Open Access titles in specific therapy areas such as Diabetes Therapy, Cardiology and Therapy and Dermatology and Therapy, previously published under the Springer Healthcare imprint. Information about the portfolio can be found on Springer.com/Adis.
We would like to thank all the authors who have contributed articles to Pediatric Drugs in the last 12 months. They have generously set aside time in their busy schedules to prepare content, and without their hard work and diligence we would not have been able to publish the journal. The quality of published articles also reflects the significant time and effort dedicated by the peer reviewers, who ensure that we continue to publish content of the highest possible standard. In addition to the members of our Honorary Editorial Board, we would like to thank the following individuals who acted as referees for articles in Pediatric Drugs in 2013:
Ishaq Abu-Arafeh, UK
Karel Allegaert, Belgium
Margarida Amaral, Portugal
Ann L. Anderson-Berry, USA
Adriano Arguedas, Costa Rica
Surabhi Batra, USA
Frederic Becq, France
M.L. Bernstein, Canada
Emma Best, New Zealand
Timothy G. Beukelman, USA
Deepak Bhatnagar, UK
Udo Bode, Germany
David A. Brent, USA
Davide Caimmi, France
Misty Carlson, USA
John P. Clancy, USA
Antonio Clavenna, Italy
David R. Coghill, UK
Alessandro Consolaro, Italy
Shyamali C. Dharmage, Australia
Okan Elidemir, USA
Cristan Farmer, USA
Jeffrey A. Feinstein, USA
Yaron Finkelstein, Canada
Michael S. Freemark, USA
Robert Frenck Jr, USA
Giovanni Gabutti, Italy
C. Gambacorti-Passerini, Italy
Silvestre García-de-la-Puente, Mexico
Madlen Gazarian, Australia
Vania Giacomet, Italy
Robert D. Goldney, Australia
J. Grill, France
Andreas H. Groll, Germany
Philip Hazell, Australia
Peter Hopkins, Australia
Kalle Hoppu, Finland
Hiroto Inaba, USA
Lorenzo Iughetti, Italy
Ignacio Jauregui, Spain
D.L. Johnston, Canada
Stephen F. Kemp, USA
Naomi Kondo, Japan
Mario La Rosa, Italy
Lucia Lee, USA
Hoan Jong Lee, Republic of Korea
Agustin Legido, USA
Kathryn Love-Osborne, USA
Marina Macchiaiolo, Italy
Maura Massimino, Italy
Sebastiano Mercadante, Italy
Kirsten Minden, Germany
Shahin Moledina, UK
Dezhi Mu, China
Sharon S.A. Nachman, USA
Roland Neumann, Switzerland
Leiv Ose, Norway
Hasan H. Ozkan, Turkey
Nikolaos G. Papadopoulos, Greece
Roman Prymula, Czech Republic
Pierre Quartier, France
C.E. Rabinovich, USA
Y. Ravindranath, USA
Michael D. Reed, USA
Stefan Rose-John, Germany
Jean-Claude Roujeau, France
Antonio Ruggiero, Italy
Ricardo A. Russo, Argentina
Gabriella Silver, USA
F. Sim, USA
Arjen J.C. Slooter, Netherlands
B. Stone, USA
Nikhil Tandon, India
Yong-Kwang Tay, Singapore
Susan B. Turkel, USA
Wendy J. Ungar, Canada
Hendrik van den Berg, Netherlands
Marcel P.H. van den Broek, Netherlands
Stijn E. Verleden, Belgium
Benedetto Vitiello, USA
Catherine Weil-Olivier, France
Johannes E. Wolff, USA
Shumpei Yokota, Japan
Christian Michel Zwaan, Netherlands
Along with our schedule of invited articles, we also encourage the submission of high-quality reviews and original research articles. We would like to remind to you keep Pediatric Drugs in mind when deciding where to submit your research. We also welcome comment from our readers on any of our articles.
We look forward to your continued support of the journal in 2014 and to bringing you first-class content from around the globe. With best wishes from the staff of Pediatric Drugs and all at Adis Publications.
Rights and permissions
About this article
Cite this article
Acknowledgement to Referees. Pediatr Drugs 15, 425–426 (2013). https://doi.org/10.1007/s40272-013-0056-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40272-013-0056-y